Back to Results
First PageMeta Content
Couillard / Health / Medicine / Transmissible spongiform encephalopathies / Philippe Couillard / Creutzfeldt–Jakob disease


2009-Oct-01 Coulillard appointment Final
Add to Reading List

Document Date: 2010-06-16 13:54:35

Open Document

File Size: 190,83 KB

Share Result on Facebook

City

Montreal / /

Company

AMF / Persistence Capital Partners / Amorfix Amorfix Life Sciences Ltd. / Amorfix Life Sciences / /

Country

France / Saudi Arabia / Canada / /

/

Event

Employment Change / Person Travel / /

Facility

St. Luc Hospital / University of Sherbrooke / McGill University / Centre Hospitalier Universitaire de Sherbrooke / /

/

IndustryTerm

healthcare system / diagnostic devices / health law / theranostics company developing therapeutic products / healthcare sector / /

MedicalCondition

brain wasting diseases / Alzheimer’s Disease / variant Creutzfeldt-Jakob Disease / Cancer / brain-wasting diseases / diseases / /

Organization

Faculty of Medicine / ITS BOARD OF DIRECTORS TORONTO / St. Luc Hospital / McGill University / University of Sherbrooke / Quebec National Assembly / Centre Hospitalier Universitaire de Sherbrooke / /

Person

Graham Strachan / Philippe Couillard / James Parsons / /

/

Position

Chief Financial Officer / Chairman / professor / neurosurgeon / director and chief surgeon of the department / George Adams President & Chief Executive Officer / Minister of Health / chief of the department / serving health minister / board member / Chairman of Board of Directors / /

ProvinceOrState

Quebec / Ontario / /

Technology

antibodies / Neurosurgery / /

SocialTag